San Francisco startup Construction Therapeutics can be working on an oral, at the time-each day GLP-one drug identified as GSBR-1290—the drug surpassed Wall Avenue’s anticipations in June each time a mid-phase analyze confirmed normal weight loss of all over 6% and it strategies to begin A different mid-phase demo to the top of the year—that